| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 02/18/2010 | CA2735392A1 Bi-aryl aminotetralines |
| 02/18/2010 | CA2734104A1 Substituted aminotetralines |
| 02/18/2010 | CA2732210A1 Monoaryl aminotetralines |
| 02/17/2010 | EP2152667A1 Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives |
| 02/16/2010 | US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/11/2010 | WO2010017470A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | WO2010015655A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 02/11/2010 | WO2010015613A1 Organic compounds |
| 02/11/2010 | US20100035996 Glucose metabolism stimulating agent |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | CA2732932A1 Organic compounds |
| 02/11/2010 | CA2732887A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 02/11/2010 | CA2732883A1 C7-fluoro substituted tetracycline compounds |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | CN101643440A Nimesulide compound and purification method thereof |
| 02/10/2010 | CN100588401C Method for preparing sulfonamide compound liposome and its formulation |
| 02/09/2010 | US7659351 Water- and oil-repellent fluoroacrylates |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | CA2379277C Polymer electrolyte and process for producing the same |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010013567A1 Amide derivative, pest control agent containing the amide derivative and pest controlling method |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | CA2737348A1 Amide derivative, pest control agent containing the amide derivative, and pest controlling method |
| 02/03/2010 | EP2149568A1 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 02/02/2010 | US7655675 Gamma-secretase inhibitors |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | CA2587149C Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds |
| 01/28/2010 | WO2010010080A1 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 01/28/2010 | WO2010010079A1 Diagnostic agents selective against metalloproteases |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/28/2010 | US20100022781 Trypsin-like serine protease inhibitors, and their preparation and use |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022601 Sulfonamide compounds and the use |
| 01/27/2010 | EP2146959A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN100584827C Chiral sulfonamide aminol ligand, its preparing method and application |
| 01/27/2010 | CN100584826C Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity |
| 01/26/2010 | CA2350031C N-arylsulfonylamino acid omega-amides |
| 01/26/2010 | CA2188817C Angiogenesis inhibitor |
| 01/21/2010 | WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity |
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | WO2009145989A3 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 01/21/2010 | US20100016380 TNF-alpha production inhibitors |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/20/2010 | EP2145883A1 Dibenzyl lipoic acid derivatives and their use in treatment of disease |
| 01/20/2010 | EP2145873A1 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode |
| 01/20/2010 | EP1963277B1 Fluorinated compounds |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | CN100582091C Bis-aryl sulfonamides |
| 01/20/2010 | CN100582089C N-substituted p-menthane carbosamided |
| 01/20/2010 | CN100582088C Aminoalcohol derivatives |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/19/2010 | US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/14/2010 | WO2010004957A1 Chiral iridium aqua complex and method for producing optically active hydroxy compound using the same |
| 01/14/2010 | WO2010004580A2 Process for preparing indole derivatives |
| 01/14/2010 | CA2729767A1 Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same |
| 01/13/2010 | EP2142499A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use |
| 01/13/2010 | EP1399414B1 Substituted tetracycline compounds for the treatment of malaria |
| 01/13/2010 | CN101624359A Preparation method for Methyl benzenesulfonyl isocyanate |
| 01/13/2010 | CN100579958C Racemized tamsulosin free alkali and preparation method thereof |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645780 N-[(1S,2R)-3-{[1-(3-bromophenyl)cyclopropyl]amino}-1-(3,5-difluorobenzyl)-2-hydroxypropyl]acetamide hydrochloride; for Alzheimer's disease; inhibitors of beta-secretase |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2009138758A3 Bis-aryl compounds for use as medicaments |
| 01/07/2010 | WO2009088549A3 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 01/07/2010 | US20100004339 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
| 01/07/2010 | US20100004295 Hydrazine amide derivative |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/06/2010 | EP2141147A1 Ornithine derivative |
| 01/06/2010 | EP2139851A2 Substituted amide derivatives |
| 01/06/2010 | EP2139850A1 Inhibitors of histone deacetylase |
| 01/06/2010 | CN100577640C Method for preparing CPLA2 inhibitors |
| 01/05/2010 | US7642367 Diamino-functional chalcones |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326274 Sulphonylated Diphenylethylenediamines, Method for Their Preparation and Use in Transfer Hydrogenation Catalysis |
| 12/31/2009 | US20090326039 Inhibitors for the soluble epoxide hydrolase |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325908 9-substituted minocycline compounds |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009157399A1 Sulfonamide compound or salt thereof |
| 12/30/2009 | WO2009111277A9 Imidazo [4. 5-b] pyridine derivatives used as raf inhibitors |
| 12/30/2009 | EP2137141A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 12/30/2009 | EP1430019B1 Sphingolipids |
| 12/30/2009 | CN101613310A Method of preparing amine stereoisomers |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CA2728511A1 Sulfonamide compounds or salts thereof |
| 12/30/2009 | CA2727340A1 Carboxylic acid compound |
| 12/29/2009 | US7638649 Method of preparation of (R)-(−)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide |
| 12/29/2009 | US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders |
| 12/29/2009 | CA2477851C Small molecule entry inhibitors |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/24/2009 | US20090318711 Non-Covalent Inhibitors of AmpC ß-Lactamase |
| 12/24/2009 | US20090318703 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient |
| 12/24/2009 | US20090318511 Selective hydroxamate based mmp inhibitors |